Effect of chlormadinone acetate, a synthetic progesterone, on hypoxic ventilatory response in men.

Ten healthy young males were studied with a double-blind, cross-over trial to determine whether or not chlormadinone acetate (CMA), a potent synthetic progesterone, augments hypoxic chemosensitivity. Seven days after CMA administration, inspiratory minute volume (VI) and tidal volume (VT) significantly increased. PaCO2 decreased by 3.0 +/- 2.6 (S.D.) Torr (p less than 0.05) and plasma bicarbonate decreased by 2.9 +/- 1.1 mM (p less than 0.01). During CMA administration, the atmospheric hypoxic ventilatory response (HVR), assessed by minute ventilatory (delta VI/delta SaO2), and occlusion pressure responses (delta P .2/delta SaO2), significantly increased about 1.9 (p less than 0.05) and 1.6 times (p less than 0.01) compared to the placebo response, respectively. The calculated normocapnic HVR (delta VI/delta SaO2) increased about 2.3 times the placebo run. Hypoxic response evaluated by the withdrawal test, which represents the peripheral chemosensitivity without involving the influence due to secondary hypoxic depression, was about 1.7 times the placebo response (p less than 0.05). We conclude that CMA augments hypoxic respiratory chemosensitivity.

[1]  H. Kimura,et al.  Effect of chlormadinone acetate, a synthetic progesterone, on restoring impaired load compensation in chronic obstructive pulmonary disease. , 1986, The Tohoku journal of experimental medicine.

[2]  H. Kimura,et al.  Effect of chlormadinone acetate on ventilatory control in patients with chronic obstructive pulmonary disease. , 1986, The American review of respiratory disease.

[3]  L. Moore,et al.  Progesterone receptors and ventilatory stimulation by progestin. , 1986, Journal of applied physiology.

[4]  H. Kimura,et al.  Augmentation of CO2 drives by chlormadinone acetate, a synthetic progesterone. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

[5]  N. Takano.  Reflex hypoxic drive to respiration during the menstrual cycle. , 1984, Respiration physiology.

[6]  D. White,et al.  Sexual influence on the control of breathing. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[7]  D. Pierson,et al.  Respiratory drives and exercise in menstrual cycles of athletic and nonathletic women. , 1981, Journal of applied physiology: respiratory, environmental and exercise physiology.

[8]  D. Pierson,et al.  Effect of medroxyprogesterone acetate on respiratory drives and occlusion pressure. , 1980, Bulletin europeen de physiopathologie respiratoire.

[9]  J. Severinghaus,et al.  Hypoxic chemosensitivity in asthmatic patients two decades after carotid body resection. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.

[10]  J. Weil,et al.  Effects of progesterone on chemosensitivity in normal men. , 1978, The Journal of laboratory and clinical medicine.

[11]  J. Dempsey,et al.  Ventilatory response to medroxyprogesterone acetate in normal subjects: time course and mechanism. , 1978, Journal of applied physiology: respiratory, environmental and exercise physiology.

[12]  J. Weil,et al.  Treatment of excessive polycythemia of high altitude with respiratory stimulant drugs. , 1978, The American review of respiratory disease.

[13]  A S Slutsky,et al.  A mathematical expression to describe the ventilatory response to hypoxia and hypercapnia. , 1977, Respiration physiology.

[14]  J. Weil,et al.  Progesterone for outpatient treatment of Pickwickian syndrome. , 1975, Annals of internal medicine.

[15]  A. Rebuck,et al.  A clinical method for assessing the ventilatory response to hypoxia. , 2015, The American review of respiratory disease.

[16]  R. Kraay,et al.  CHLORMADINONE ACETATE, A NEW HIGHLY ACTIVE GESTATION-SUPPORTING AGENT. , 1963, Acta endocrinologica.

[17]  P. Dejours.  Chemoreflexes in breathing. , 1962, Physiological reviews.